Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Anti-CD38 A2 DAR T Cells for Multiple Myeloma
Recruiting1 awardPhase 1
Oklahoma City, Oklahoma
This trial tests a new drug called STI-1492 for patients whose multiple myeloma has returned or not responded to other treatments. The drug is given through an IV, and the dose is gradually increased to find the safest and most effective amount.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service